Asthma Exacerbations and Vascular Function

NACompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

December 31, 2020

Study Completion Date

December 31, 2020

Conditions
Asthma
Interventions
DRUG

Mannitol

Mannitol consists of inhaling 0 (empty capsule acting as a placebo), 5, 10, 20, 40, 80, 160, 160, and 160 mg mannitol, resulting in a maximum cumulative dose of 635 mg

DRUG

Methacholine

Methacholine consists of inhaling 0.0625 mg/mL, 0.25 mg/mL, 1 mg/mL, 4 mg/mL, and 16 mg/mL

DRUG

Placebo

Placebo consists of inhaling humidified air

OTHER

Rest

OTHER

Exercise

Trial Locations (1)

T6G 2J1

Clinical Physiology Research Laboratory, Edmonton

All Listed Sponsors
lead

University of Alberta

OTHER

NCT02630511 - Asthma Exacerbations and Vascular Function | Biotech Hunter | Biotech Hunter